Suscribirse

Evolution of diagnostic criteria for acute kidney injury in patients with decompensated cirrhosis: A prospective study in a tertiary university hospital - 03/09/20

Doi : 10.1016/j.clinre.2019.07.004 
Nayana Fonseca Vaz a, Vanessa Nogueira Rodrigues da Cunha a, Marlone Cunha-Silva a, Tiago Sevá-Pereira a, Jazon Romilson de Souza Almeida a, Daniel F. Mazo a, , b
a Division of Gastroenterology (Gastrocentro), School of Medical Sciences, University of Campinas (UNICAMP), Rua Carlos Chagas n°420, 13083-878 Campinas, Brazil 
b Division of Clinical Gastroenterology and Hepatology, Department of Gastroenterology, University of São Paulo School of Medicine, Avenida Dr. Enéas de Carvalho Aguiar n°255, Instituto Central, 9159 Sao Paulo, Brazil 

Corresponding author.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

páginas 13
Iconografías 4
Vídeos 0
Otros 0

Highlights

In Brazil, there is a paucity of data and analyses regarding acute kidney injury (AKI) in accordance with ICA-AKI criteria in hospitalized patients with decompensated cirrhosis.
The MELD score and use of furosemide were independently associated with acute kidney injury in this scenario.
In-hospital mortality was associated with worse liver function, AKI, infection and the presence of shock. Serum creatinine>1,5mg/dL remained an important prognostic factor.

El texto completo de este artículo está disponible en PDF.

Summary

Background

Recently, changes in acute kidney injury (AKI) diagnostic criteria have been proposed (ICA-AKI criteria). However, in Brazil there is a paucity of data and analyses that evaluate AKI in patients with cirrhosis and determine the impact of the implemented AKI criteria changes. Therefore, this study sought to evaluate the incidence of AKI in patients with cirrhosis; to evaluate the agreement between traditional and ICA-AKI criteria; and to assess its clinical and laboratory characteristics, etiologies, risk factors and outcomes.

Methods

This is a prospective cohort study in hospitalized patients with cirrhosis and acute decompensation. The total number of hospitalizations was evaluated using the PWP statistical model for recurring events; P values<0.05 were considered significant.

Results

A total of 154 admissions of 75 patients were included in the study. Among the hospitalizations, 89 (57.79%) met the ICA-AKI criteria. There was substantial agreement between both AKI classifications (Kappa 0.7293). The main etiology of AKI was pre-renal (59.55%), followed by renal (26.96%) and hepatorenal syndrome (10.11%). A multivariate analysis uncovered risk factors for ICA-AKI, including the MELD score (P=0.0162, RR:1.055, 95% CI:1.010–1.101) and the use of furosemide (P=0.001,RR:2.360, 95% CI:1.417-3.931). A univariate analysis found an association between in-hospital mortality and serum creatinine (sCr)1.5mg/dL(P=0.0373), MELD (P=0.0296), bilirubin (P=0.0064), and infection (P=0.0045), while in the multivariate analysis, the bilirubin levels (P=0.0030, RR:1.077, 95% CI: 1.025–1.130) and the presence of shock (P=0.0002, RR:8.511, 95% CI: 2.746–26.377) were associated with in-hospital mortality. Among the hospitalizations with AKI, death was significantly associated with non-response to treatment and dialysis. Initial stage 1A-AKI had lower in-hospital mortality than stage 1B-AKI.

Conclusions

AKI incidence was high in this cohort of patients with decompensated cirrhosis, and substantial agreement between AKI definitions was observed. In-hospital mortality was associated with worse liver function, AKI, infection and the presence of shock. Also, sCr>1,5mg/dL remained an important prognostic factor.

El texto completo de este artículo está disponible en PDF.

Keywords : Cirrhosis, Acute kidney injury, ICA-AKI criteria, Mortality


Esquema


© 2019  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 44 - N° 4

P. 551-563 - septembre 2020 Regresar al número
Artículo precedente Artículo precedente
  • Effect of mycophenolic acid on inosine monophosphate dehydrogenase (IMPDH) activity in liver transplant patients
  • M. Neuberger, C. Sommerer, S. Böhnisch, N. Metzendorf, A. Mehrabi, W. Stremmel, D. Gotthardt, M. Zeier, K.H. Weiss, C. Rupp
| Artículo siguiente Artículo siguiente
  • Anastomotic bilio-biliary stricture after adult liver transplantation: A retrospective study over 20 years in a single center
  • Jérôme Dumortier, Christine Chambon-Augoyard, Olivier Guillaud, Mathieu Pioche, Jérôme Rivory, Pierre-Jean Valette, Mustapha Adham, Thierry Ponchon, Jean-Yves Scoazec, Olivier Boillot

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
La compra de artículos no está disponible en este momento.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.